{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:04:21Z","timestamp":1747109061740,"version":"3.40.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>Twin pregnancy presents unique considerations for aneuploidy screening. Pre-test counseling regarding benefits, alternatives, and options for aneuploidy screening should be provided to all patients carrying twin pregnancy. This article aims to review the options for aneuploidy screening in twin pregnancy including the potential benefits and limitations.<\/jats:p>","DOI":"10.1097\/grf.0000000000000805","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T18:00:09Z","timestamp":1689184809000},"page":"624-628","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal Genetic Screening in Twin Pregnancy"],"prefix":"10.1097","volume":"66","author":[{"given":"Lauren","family":"Buckley","sequence":"first","affiliation":[{"name":"Obstetrics & Gynecology Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Obstetrics & Gynecology Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Kuller","sequence":"additional","affiliation":[{"name":"Division of Maternal and Fetal Medicine, Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Dugoff","sequence":"additional","affiliation":[{"name":"Division of Maternal and Fetal Medicine and Reproductive Genetics, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities: ACOG Practice Bulletin, Number 226","volume":"136","author":"Bulletins\u2014Obstetrics","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/AOG.0000000000001690","article-title":"Observed rate of Down syndrome in twin pregnancies","volume":"128","author":"Sparks","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/1471-0528.12574","article-title":"Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implications for prenatal screening","volume":"121","author":"Boyle","year":"2014","journal-title":"BJOG"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1471-0528.1996.tb09550.x","article-title":"Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation","volume":"103","author":"Sebire","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajog.2012.10.880","article-title":"Twin-twin transfusion syndrome","volume":"208","author":"Simpson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/uog.8845","article-title":"A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester","volume":"37","author":"Madsen","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/pd.4431","article-title":"Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis","volume":"34","author":"Prats","year":"2014","journal-title":"Prenat Diagn"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pd.2145","article-title":"Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies","volume":"28","author":"Garchet-Beaudron","year":"2008","journal-title":"Prenat Diagn"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3892\/br.2016.611","article-title":"Second trimester maternal serum triple screening marker levels in normal twin and singleton pregnancies","volume":"4","author":"Ren","year":"2016","journal-title":"Biomed Rep"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/(SICI)1097-0223(199610)16:10<927::AID-PD972>3.0.CO;2-0","article-title":"Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down\u2019s syndrome","volume":"16","author":"Watt","year":"1996","journal-title":"Prenat Diagn"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.ajog.2021.04.212","article-title":"Obesity and no call results: optimal timing of cell-free DNA testing and redraw","volume":"225","author":"Hopkins","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.5152","article-title":"The association between anti-coagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","volume":"37","author":"Burns","year":"2017","journal-title":"Prenat Diagn"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3390\/jcm3020537","article-title":"Non-invasive prenatal testing using cell free DNA in maternal plasma: recent developments and future prospects","volume":"3","author":"Benn","year":"2014","journal-title":"J Clin Med"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/uog.23648","article-title":"Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14\u2009weeks and meta-analysis","volume":"58","author":"Judah","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R16-20250512","first-page":"00229","article-title":"Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study","author":"Dugoff","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/uog.20290","article-title":"First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure","volume":"53","author":"Galeva","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/uog.19004","article-title":"Prolonged duration of persistent cell-free fetal DNA from vanishing twin","volume":"52","author":"Niles","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/pd.5817","article-title":"Should vanishing twin pregnancies be systematically excluded from cell-free fetal DNA testing?","volume":"41","author":"Balaguer","year":"2021","journal-title":"Prenat Diagn"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/uog.21922","article-title":"First-trimester screening for trisomies in pregnancies with vanishing twin","volume":"55","author":"Chaveeva","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.semperi.2012.02.008","article-title":"Prenatal diagnosis in twin gestations","volume":"36","author":"Vink","year":"2012","journal-title":"Semin Perinatol"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/uog.22143","article-title":"Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: systematic review and meta-analysis","volume":"56","author":"Di Mascio","year":"2020","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:13:52Z","timestamp":1747062832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000805","relation":{},"ISSN":["0009-9201"],"issn-type":[{"type":"print","value":"0009-9201"}],"subject":[],"published":{"date-parts":[[2023,7,12]]}}}